160 related articles for article (PubMed ID: 12892515)
1. Raman spectral mapping in the assessment of axillary lymph nodes in breast cancer.
Smith J; Kendall C; Sammon A; Christie-Brown J; Stone N
Technol Cancer Res Treat; 2003 Aug; 2(4):327-32. PubMed ID: 12892515
[TBL] [Abstract][Full Text] [Related]
2. A grid matrix-based Raman spectroscopic method to characterize different cell milieu in biopsied axillary sentinel lymph nodes of breast cancer patients.
Som D; Tak M; Setia M; Patil A; Sengupta A; Chilakapati CM; Srivastava A; Parmar V; Nair N; Sarin R; Badwe R
Lasers Med Sci; 2016 Jan; 31(1):95-111. PubMed ID: 26552923
[TBL] [Abstract][Full Text] [Related]
3. Raman spectroscopy--a potential new method for the intra-operative assessment of axillary lymph nodes.
Horsnell JD; Smith JA; Sattlecker M; Sammon A; Christie-Brown J; Kendall C; Stone N
Surgeon; 2012 Jun; 10(3):123-7. PubMed ID: 22525413
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
6. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
Seyednejad N; Kuusk U; Wiseman SM
Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
[TBL] [Abstract][Full Text] [Related]
7. [The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings].
Cserni G; Boross G; Baltás B
Orv Hetil; 1998 Aug; 139(32):1899-903. PubMed ID: 9731445
[TBL] [Abstract][Full Text] [Related]
8. Towards the intra-operative use of Raman spectroscopy in breast cancer-overcoming the effects of theatre lighting.
Horsnell JD; Kendall C; Stone N
Lasers Med Sci; 2016 Aug; 31(6):1143-9. PubMed ID: 27220528
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in early breast cancer: the first 100 cases performed in a teaching institute.
Mahajna A; Hershko DD; Israelit S; Abu-Salih A; Keidar Z; Krausz MM
Isr Med Assoc J; 2003 Aug; 5(8):556-9. PubMed ID: 12929292
[TBL] [Abstract][Full Text] [Related]
11. Is axillary reverse mapping feasible in breast cancer patients?
Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of fine needle aspirates processed by ThinPrep® for the assessment of axillary lymph node status in patients with invasive carcinoma of the breast.
Jing X; Wey E; Michael CW
Cytopathology; 2013 Dec; 24(6):372-6. PubMed ID: 23020285
[TBL] [Abstract][Full Text] [Related]
13. Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival.
Wolberg WH; Street WN
Hum Pathol; 2002 Nov; 33(11):1086-91. PubMed ID: 12454812
[TBL] [Abstract][Full Text] [Related]
14. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
[TBL] [Abstract][Full Text] [Related]
15. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.
Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L;
Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089
[TBL] [Abstract][Full Text] [Related]
16. Is intra-operative nodal assessment essential in a modern breast practice?
Benson JR; Wishart GC
Eur J Surg Oncol; 2010 Dec; 36(12):1162-4. PubMed ID: 20880663
[No Abstract] [Full Text] [Related]
17. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.
Rutgers EJ
J Clin Oncol; 2008 Feb; 26(5):698-702. PubMed ID: 18258976
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]